TheEdgeResearch
Home / Stocks / LMAT

LeMaitre Vascular, Inc. (LMAT)

NASDAQ Healthcare Medical - Instruments & Supplies
$79.97 ▼ -3.47%
Market Cap
$1.83B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
0.52
52-Wk Range
78.65-118.01
CEO
George W. LeMaitre
Country
US
Currency
USD

LeMaitre Vascular, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Burlington, MA, US. The stock last traded at $79.97, down 3.47% on the session, giving a market capitalisation of $1.83B. On trailing twelve-month figures it carries a trailing P/E of 27.57, a net margin of 25.0%. Its beta of 0.52 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
27.57
Price / Sales
6.96
Price / Book
4.35
EV / EBITDA
20.46
Gross margin
72.9%
Operating margin
29.5%
Net margin
25.0%
Return on equity
Debt / equity
0.45
Current ratio
16.31
Dividend yield
1.1%
Payout ratio
31.2%
Company profile
Exchange
NASDAQ Global Market
Employees
651
IPO date
2006-10-19
Headquarters
Burlington, MA, US
About LeMaitre Vascular, Inc.

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Comparable companies

LeMaitre Vascular, Inc. is most often compared with the following Healthcare names:

ACHCATRCAVAHHAEINSPNHCPAHCPRCTQDELTWST
More research on LMAT
LMAT technical analysis LMAT TheEdge Score Compare against peers
Open full interactive analysis & DCF →